Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Beth Ann Smith | VP Controller Treasurer | 2025-02-15 | 423 | $2.56 | $1.08kSell |
Eric Blasius Risser | Chief Operating Officer | 2025-02-15 | 6,433 | $2.56 | $16.47kSell |
Jeffrey Stuart Peters | Senior VP and General Counsel | 2025-02-15 | 5,147 | $2.56 | $13.18kSell |
Stephen L. Eck | Chief Medical Officer | 2025-02-15 | 4,942 | $2.56 | $12.65kSell |
James Karrels | SVP CFO and Secretary | 2025-02-15 | 5,790 | $2.56 | $14.82kSell |
Thomas Spitznagel | Sr VP Technical Ops | 2025-02-15 | 5,520 | $2.56 | $14.13kSell |
Ezio Bonvini | Sr VP Research CSO | 2025-02-08 | 4,311 | $2.60 | $11.21kSell |
Stephen L. Eck | Chief Medical Officer | 2025-02-08 | 3,312 | $2.60 | $8.61kSell |
James Karrels | SVP CFO and Secretary | 2025-02-08 | 3,861 | $2.60 | $10.04kSell |
Jeffrey Stuart Peters | Senior VP and General Counsel | 2025-02-08 | 3,475 | $2.60 | $9.04kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Target N. V. Biotech | 15.82% | 9,929,963 | $20.36M | Insider |
Bellevue Group Ag | 15.82% | 9,929,963 | $20.36M | Institution |
Armistice Capital LLC | 10.00% | 6,276,000 | $12.87M | Institution |
Blackrock Inc | 8.06% | 5,057,175 | $10.37M | Institution |
Vanguard Group Inc | 6.88% | 4,316,681 | $8.85M | Institution |
Wasatch Advisors LP | 5.56% | 3,488,493 | $7.15M | Institution |
Frazier Life Sciences Management LP | 5.06% | 3,175,665 | $6.51M | Institution |
Millennium Management LLC | 4.56% | 2,864,721 | $5.87M | Institution |
Tpg Group Holdings Sbs Advisors Inc | 3.52% | 2,208,762 | $4.53M | Insider |
Scott Koenig | 3.31% | 2,076,090 | $4.26M | Insider |